Bright Streak Appears Over US During Aurora Storm, Mystifying Skywatchers
That was a night for auroral activity, as Earth's magnetic field was buffeted by an influx of particles ejected from the Sun several days earlier. Initially, explanations favored STEVE, the name given to the white-mauve streaks of light emitted by rivers of charged particles flowing through Earth's ionosphere.
STEVE is not an aurora, but, like the auroral displays it often appears alongside, is also a product of space weather.
Spoiler though: the light was not actually STEVE, but a rocket stage dumping out methalox rocket fuel at an altitude of about 250 kilometers (155 miles), bang in the ionosphere, according to astronomer Jonathan McDowell, who tracks activity in Earth space.
At 04:12 UTC, Beijing-based startup LandSpace Technology launched its new Zhuque-2E Y2 methane-fueled carrier rocket, bearing six satellites into Earth orbit. About an hour later, the bright stripe appeared in the sky – not far from midnight over much of the US. That stripe, according to McDowell, was the result of a fuel dump from the rocket's upper stage.
Rocket fuel made from methane and liquid oxygen, known as methalox, is a relatively recent development; LandSpace was the first company to successfully launch a methalox rocket, back in 2023, and this is the fifth flight for its Zhuque-2 series, the company said in a statement.
Methalox is attractive to the aerospace industry because it is cheaper, cleaner, and easier to store, and it may be able to be produced on Mars. That would make crewed missions to the red planet more efficient, since the spacecraft would not need to carry the fuel for the return journey from the outset.
Rocket fuel can glow in the upper atmosphere through several mechanisms. One, seen close to twilight hours, is the illumination of ice particles by the light of the Sun. Closer to midnight, the Sun would be too far around the other side of Earth to be able to illuminate particles, even those high in the atmosphere.
In the ionosphere, molecules involving carbon, hydrogen, and oxygen can generate chemical reactions that produce light. Carbon and hydrogen are the components of methane.
"The reactions [of rocket fuel] with the plasma in the ionosphere include ion-molecule charge exchange, electron-ion recombination, and optical emissions from chemiluminescence," a team of physicists led by Paul Bernhardt of the US Naval Research Laboratory explained in a 2012 paper.
"If the plume is fired into the ionosphere at night, chemiluminescent reactions with ion-molecule charge exchange followed by electron-ion dissociative recombination yield a long-lived glow that can be observed from ground or space."
Anybody know what this light could be? byu/Ambitious_Amount_357 inAstronomy
Usually, the glowing fuel of a rocket blasting into space manifests as a strange spiral in the sky. Rocket fuel masquerading as STEVE is a new experience, but it sure is pretty.
Methalox is gaining traction, with more rocket companies investigating its use. Perhaps more such streaks will appear in the sky. If you see one, now you might know what you're looking at.
TRAPPIST-1 Planets Could Be Swimming in Water, Study Shows
Unknown Species of Bacteria Discovered in China's Space Station
NASA Mission Captures Eerie New View of The Moon And Sun
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Wild orcas will sometimes offer food to humans
Orcas (Orcinus orca) don't appear to be big fans of yachts, but some of them may be curious about humans themselves. According to a study published on June 30 in the Journal of Comparative Psychology, cetology researchers have confirmed dozens of instances of killer whales intentionally approaching people and offering them food—a behavior they typically reserve for building bonds between orca pods. 'Orcas often share food with each other—it's a prosocial activity and a way that they build relationships with each other,' Jared Towers, a study lead author and executive director of the British Columbia-based research organization Bay Cetology said in a statement. 'That they also share with humans may show their interest in relating to us as well.' Towers collaborated with Vanessa Prigollini at Mexico's Marine Education Association along with killer whale expert Ingrid Visser at the Orca Research Trust in New Zealand to collect incidents of the apex predators voluntarily meeting people. They ultimately confirmed 34 events spanning the last two decades. In total, 11 instances involved orcas approaching humans swimming in water, 21 cases occurred while people were on boats, and another two examples were recorded from shore. However, the researchers didn't simply take witnesses at their word. In order to be included in the study, a potential documentation needed to meet stringent criteria after reviewing any video and photographic evidence, as well as subject interviews. In each event, the orcas must have approached humans of their own volition, then dropped an item in front of them. The whales varied in both age and sex, but all except one appeared to wait for a reaction. In some cases, they even reattempted their food offers—a mix of fish, mammals, invertebrates, birds, as well as one reptile and one piece of seaweed. 'Offering items to humans could simultaneously include opportunities for killer whales to practice learned cultural behavior, explore or play and in so doing learn about, manipulate or develop relationships with us,' the researchers wrote in the study. 'Giving the advanced cognitive abilities and social, cooperative nature of this species, we assume that any or all these explanations for, and outcomes of such behavior are possible.' The team added these may be the first in-depth descriptions of non-domesticated animals behaving in ways that are usually reserved for household pets like cats and dogs. They may also mark the first accounts of wild predators purposefully employing prey and other objects to 'directly explore human behavior.' If true, these instances 'may highlight the evolutionary convergence of intellect between highest order primates and dolphins.'


Business Wire
14 hours ago
- Business Wire
From Waste to Watts: Argonne is Unlocking the Power in Used Nuclear Fuel
LEMONT, Ill.--(BUSINESS WIRE)--Nuclear reactors across the U.S. generate used fuel, but more than 95% of that fuel still holds valuable energy. Through advanced chemical processes and new technologies, scientists aim to recycle this material to generate more power and reduce long-term radioactive waste. Researchers are now working to make this potential a practical, scalable solution. Scientists at the U.S. Department of Energy's Argonne National Laboratory are partnering with SHINE Technologies, a Wisconsin-based company, to design a new process for separating valuable materials from used nuclear fuel. The process employs innovative equipment, including centrifugal contactors—spinning devices that efficiently separate mixed liquids—to create a safer, more efficient recycling method ready for industrial use. 'Bridging scientific research and industrial implementation is critical,' said Candido Pereira, deputy division director of Argonne's Chemical and Fuel Cycle Technologies (CFCT) division. 'Our team is committed to supporting the private sector with world-class solutions.' Recycling used nuclear fuel is complex. It's highly radioactive, generates heat, and must be safely stored and cooled. Facilities need systems to manage small amounts of leftover material. Nuclear material also requires strict safeguards to prevent unauthorized use. Scientists apply 'safeguards by design' early in development to ensure compliance and security. Economic viability is another hurdle. Recovered materials need practical applications and buyers. Some utilities may use recycled fuel in advanced reactors. Other byproducts—such as radioisotopes—can power space missions or be used in medical diagnostics. If demand exists, building recycling facilities becomes more feasible. Foresight is essential. Scientists must anticipate how future reactors will use fuel and what materials they'll require. Experts at national labs like Argonne are uniquely positioned to predict these needs and tailor recycling processes. Peter Tkac, nuclear chemist and manager of Argonne's CFCT Radiochemistry Group, leads the effort. 'It's important we develop a process that doesn't produce a pure plutonium stream,' he said, citing security risks. Tkac's team uses a Van de Graaff accelerator to simulate radiation conditions and test chemical durability in safe lab environments, speeding innovation. Tkac's group also collaborates with SHINE to test Argonne's centrifugal contactors. Using 3D printing, they build custom prototypes of different designs, allowing rapid, cost-effective testing. 'Recycling used nuclear fuel is complicated,' said Tkac. 'But with the right strategy, we can reduce waste, improve energy supply, and support the future of nuclear power.'
Yahoo
15 hours ago
- Yahoo
Carthera's ultrasound system earns EMA endorsement as an orphan medical device
Carthera has received an orphan medical device status endorsement for its SonoCloud ultrasound system for treating brain disorders under a new pilot programme by the European Medicines Agency (EMA). The France-based company's SonoCloud system delivers ultrasound to temporarily open the blood-brain barrier. Activated ahead of drug administration, the skull implant is intended to allow therapeutic agents to better reach the brain. Past research has shown that the blood-brain barrier, a natural filtration system of the brain, limits the penetration of more than 98% of drugs. The endorsement means that Carthera will benefit from advice, including support around its clinical development strategy and clarification on the final steps before filing a European CE mark application for its SonoCloud system, from an EMA expert panel. Intended for medical device manufacturers and notified bodies, the endorsement is part of an EU pilot programme to support early access pathways for innovative devices targeting rare diseases. As part of the programme, the EMA has prioritised certain types of orphan medical devices such as those treating life-threatening medical conditions or those that could cause permanent impairment of a bodily function, and novel devices with potential major clinical benefits. 'This is a very important step for the company, since it creates a unique forum for dialogue with the expert panel prior to submitting the technical documentation for conformity assessment,' said Sandra Thiollière, director of regulatory affairs at Carthera. 'In parallel, we are continuing our early-stage contacts with our notified body to prepare for CE marking submission.' Carthera is currently evaluating SonoCloud in improving the treatment of recurrent glioblastoma (rGBM). In 2024, the Sorbonne University spinout shared results from a Phase I/II single-arm trial (NCT03744026) assessing the safety and efficacy of blood-brain barrier disruption with an implantable ultrasound system in rGBM patients receiving carboplatin. In 12 patients who received carboplatin just before using the device, the one-year overall survival rate (OSR) was 58%, with a median OS of 14 months from surgery. The historical rate of survival for patients living with rGBM is around 9-11 months. Carthera is currently recruiting patients for a pivotal trial of SonoCloud. The two-arm trial will enrol 560 patients and evaluate the system combined with carboplatin (CBDCA) versus standard of care, lomustine (CCNU) or temozolomide (TMZ), in patients undergoing planned resection for first recurrence glioblastoma. "Carthera's ultrasound system earns EMA endorsement as an orphan medical device" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.